Showing results (31-40 of 37) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Bioorganic & Medicinal Chemistry Letters|February 5, 2003
Design, synthesis and structure-activity relationships of benzoxazinone-based factor Xa inhibitorsWenrong Huang, Penglie Zhang, Jingmei F Zuckett, et al.Bioorganic & Medicinal Chemistry Letters|April 15, 2004
N,N-Dialkylated 4-(4-arylsulfonylpiperazine-1-carbonyl)-benzamidines and 4-((4-arylsulfonyl)-2-oxo-piperazin-1-ylmethyl)-benzamidines as potent factor Xa inhibitorsZhaozhong J Jia, Ting Su, Jingmei F Zuckett, et al.Bioorganic & Medicinal Chemistry Letters|May 29, 2002
Design, synthesis, and SAR of substituted acrylamides as factor Xa inhibitorsYonghong Song, Lane Clizbe, Chhaya Bhakta, et al.Plos One|June 7, 2023
CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunityKathleen M C Sullivan, Marta Vilalta, Linda S Ertl, et al.Nature Communications|March 12, 2020
Cancer associated fibroblast FAK regulates malignant cell metabolismFevzi Demircioglu, Jun Wang, Juliana Candido, et al.Bioorganic & Medicinal Chemistry Letters|March 20, 2009
Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitorPenglie Zhang, Wenrong Huang, Lingyan Wang, et al.Cell|May 31, 2020
Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regulated Crosstalk with Tumor CellsPing-Pui Wong, José M Muñoz-Félix, Maruan Hijazi, et al.Pageof 4